期刊文献+

宫颈癌放化疗后并发治疗相关性骨髓增生异常综合征/急性髓系白血病一例报告并文献复习 被引量:3

原文传递
导出
摘要 宫颈癌是妇科常见肿瘤之一,经手术联合放、化疗综合治疗,患者生存期显著延长,5年生存率达77.52%^[1]。治疗相关性骨髓增生异常综合征(MDS)/急性髓系白血病(AML)是长期存活患者的远期并发症之一,但目前尚无其发病率的流行病学研究^[2]。我们报道1例宫颈癌放、化疗后并发治疗相关性MDS/AML患者,并进行了文献复习。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2012年第2期138-140,共3页 Chinese Journal of Hematology
基金 国家自然科学基金(81070403)
  • 相关文献

参考文献23

  • 1廖震华,陈增春,陈桂林,黄燕玲,陈炜,魏东红,田俊.190例宫颈癌患者临床病理特征及预后分析[J].中国肿瘤,2010,19(4):283-286. 被引量:13
  • 2Chaturvedi AK,Engels EA,Gilbert ES,et al.Second cancers among 104760 survivors of cervical cancer:evaluation of long-term risk.J Natl Cancer Inst,2007,99:1634-1643.
  • 3杨艺红,徐泽锋,张乃红,郝玉书,肖志坚.一例多发性骨髓瘤治疗相关性骨髓增生异常综合征[J].中华血液学杂志,2008,29(4):270-271. 被引量:9
  • 4Leone G,Pagano L,Ben-yehuda D,et al.Therapy-related leukemia and myelodysplasia:susceptibility and incidence.Haematologica,2007,92:1389-1398.
  • 5Smith SM,Le Beau MM,Huo D,et al.Clinical-cytogenetics associations in 306 patients with therapy-related myelodysplastic and myeloid leukemia:the University of Chicago series. Blood,2003,102:43-52.
  • 6Leone G,Fianchi L,Pagano L,et al.Incidence and susceptibilty to therapy-related myeloid neoplasms.Chem Biol Interact,2010,184:39-45.
  • 7Travis LB,Holowaty E J,Bergfeldt K,et al.Risk of leukemia after platinum-based chemotherapy for ovarian cancer.N Engl J Med,1999,340:351-357.
  • 8McLaughlin P,Estey E,Glassman A,et al.Myelodysplastic and acute myeloid leukemia following therapy for indolent lymphoma with fludarabin,mitoxantrone,and dexamethasone(FND) plus rituximab and interferon alpha.Blood,2005,105:4573-4575.
  • 9Metayer C,Curtis RE,Vose J,et al.Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma:a multicenter case-control.Blood,2003,101:2015-2023.
  • 10Mays AN,Osheroff N,Xiao Y,et al.Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t (15; 17) therapy-related acute promyelocytic leukemia.Blood,2010,115:326-360.

二级参考文献15

  • 1肖志坚.骨髓增生异常综合征的诊断和治疗认识现况[J].国际输血及血液学杂志,2007,30(1):1-4. 被引量:9
  • 2Amiel A, Yukla M, Yogev S, et al. Deletion of 5q31 and 7q31 in patients with stable melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 2004, 152 : 84-87.
  • 3Ishii Y, Hsiaoa HH, Sashidaa G, et al. Derivative (1;7)(q10; p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome. Cancer Genet Cytogenet, 2006, 167: 131- 137.
  • 4Mauritzson N, Albin M, Rylander L, et al. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia, 2002, 16: 2366-2378.
  • 5Rodjer S, Swolin B, Weinfeld A, et al. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma. Cancer Genet Cytogenet, 1990, 48 : 67-73.
  • 6Nilsson T, Nilsson L, Lenhoff S, et al. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance : evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q). Genes Chromosomes Cancer, 2004, 41 : 223-231.
  • 7Van DP, Lie AK, Vach W, et al. Risk grouping in stage Ⅰ b squamous cell cervical carcinoma [J]. Gynecol Oncol 2005, 99(1):106-112.
  • 8Memarzadeh S, Natarajan S, Dandade DP, et al. Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer[J]. Obstet Gynecol, 2003, 102(3): 612-619.
  • 9Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy [J]. Gynecol Oncol, 2004, 93 (2):458-464.
  • 10Peters Ⅲ WA, Liu R, Barrett Ⅱ R J, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix [J]. J Clin Oncol, 2000,18(8):1606-1613.

共引文献19

同被引文献36

  • 1王战营,郭宏岗,张莳,张艳灵,唐家宏.HAG方案治疗老年急性髓系白血病16例疗效分析[J].中国医师进修杂志,2012,35(S02):57-58. 被引量:3
  • 2展昭民,陈德发,吴红菊,贡铁军,任实,郝文鹏,唐庆华,关小军,张伯龙,马军.治疗相关性白血病的治疗[J].癌症进展,2005,3(2):106-109. 被引量:12
  • 3吴意红,祝文娟.预激方案治疗老年急性髓性白血病17例临床分析[J].安徽医药,2005,9(12):931-931. 被引量:1
  • 4Leone G,Fianchi L,Pagano L,et al.Incidence and susceptibility totherapy-related myeloid neoplasms[J].Chem Biol Interact,2010,184(1/2):39-45.
  • 5Smith SM,Le Beau MM,Huo D,et al.Clinical-cytogenetic associa-tions in 306 patients with therapy-related myelodysplasia and mye-loid leukemia:the University of Chicago series[J].Blood,2003,102(1):43-52.
  • 6Howard RA, Gilbert ES, Chen BE, et al. Leukemia following breast cancer: an international population-based study of 376, 825 women[J]. Breast Cancer Res Treat, 2007, 105 (3): 359- 368.
  • 7Praga C, Bergh J, Bliss J, et al. and myelodysplastic syndrome Risk of acute myeloid leukemia in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclophosphamide [ J ]. J Clin Oncol, 2005, 23 (18): 4179-4191.
  • 8Tallman MS, Gray R, Bennett JM, et al. Leukemogenic potential of adjuvant chemotherapy for early-stage breast cancer: the East- em Cooperative Oncology Group experience [J]. J Clin Oncol, 1995, 13(7): 1557-1563.
  • 9Valagussa P, Molitemi A, Terenziani M, et al. Second malignan- cies following CMF-based adjuvant chemotherapy in resectable breast cancer[J]. Ann Oncol, 1994, 5(9): 803-808.
  • 10Curtis RE, Boice JD Jr, Stovall M, et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer [Jl. N Engl J Med, 1992, 326(26): 1745-1751.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部